---
layout: article
title: "Publication List"
excerpt: "Journal articles associated with the TIGR Lab."
ads: false
share: false
image:
  feature: banner.publications.jpg
  teaser: teaser.publications.jpg
---

Please visit [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/?term=voineskos+a) for list of our publications. Updated on 26th Feb, 2016.


1: Lett TA, Kennedy JL, Radhu N, Dominguez LG, Chakravarty MM, Nazeri A, Farzan
F, Walter H, Heinz A, Mulsant BH, Daskalakis ZJ, Voineskos AN. Prefrontal White
Matter Structure Mediates the Influence of GAD1 on Working Memory.
Neuropsychopharmacology. 2016 Jan 29. doi: 10.1038/npp.2016.14. [Epub ahead of
print] PubMed PMID: 26822489.


2: Brown EE, Graff-Guerrero A, Houle S, Mizrahi R, Wilson AA, Pollock BG, Mulsant
BH, Felsky D, Voineskos AN, Tang-Wai DF, Verhoeff NP, Freedman M, Ismail Z, Chow 
TW. Amyloid deposition in semantic dementia: a positron emission tomography
study. Int J Geriatr Psychiatry. 2016 Jan 25. doi: 10.1002/gps.4423. [Epub ahead 
of print] PubMed PMID: 26807731.


3: Felsky D, De Jager PL, Schneider JA, Arfanakis K, Fleischman DA, Arvanitakis
Z, Honer WG, Pouget JG, Mizrahi R, Pollock BG, Kennedy JL, Bennett DA, Voineskos 
AN; authors of the Alzheimer’s Disease Neuroimaging Initiative. Cerebrovascular
and microglial states are not altered by functional neuroinflammatory gene
variant. J Cereb Blood Flow Metab. 2016 Jan 13. pii: 0271678X15626719. [Epub
ahead of print] PubMed PMID: 26762507.


4: Roostaei T, Sadaghiani S, Park MT, Mashhadi R, Nazeri A, Noshad S, Salehi MJ, 
Naghibzadeh M, Moghadasi AN, Owji M, Doosti R, Taheri AP, Rad AS, Azimi A,
Chakravarty MM, Voineskos AN, Nazeri A, Sahraian MA. Channelopathy-related SCN10A
gene variants predict cerebellar dysfunction in multiple sclerosis. Neurology.
2016 Feb 2;86(5):410-7. doi: 10.1212/WNL.0000000000002326. Epub 2016 Jan 6.
PubMed PMID: 26740675.


5: Tsoutsoulas C, Mulsant BH, Kalache SM, Kumar S, Ghazala Z, Voineskos AN,
Butters MA, Menon M, Rajji TK. The influence of medical burden severity and
cognition on functional competence in older community-dwelling individuals with
schizophrenia. Schizophr Res. 2016 Feb;170(2-3):330-5. doi:
10.1016/j.schres.2015.12.009. Epub 2015 Dec 24. PubMed PMID: 26724896.


6: Voineskos AN, Felsky D, Wheeler AL, Rotenberg DJ, Levesque M, Patel S, Szeszko
PR, Kennedy JL, Lencz T, Malhotra AK. Limited Evidence for Association of
Genome-Wide Schizophrenia Risk Variants on Cortical Neuroimaging Phenotypes.
Schizophr Bull. 2015 Dec 27. pii: sbv180. [Epub ahead of print] PubMed PMID:
26712857.


7: Behdinan T, Foussias G, Wheeler AL, Stefanik L, Felsky D, Remington G, Rajji
TK, Mallar Chakravarty M, Voineskos AN. Neuroimaging predictors of functional
outcomes in schizophrenia at baseline and 6-month follow-up. Schizophr Res. 2015 
Dec;169(1-3):69-75. doi: 10.1016/j.schres.2015.10.023. Epub 2015 Oct 24. PubMed
PMID: 26603060; PubMed Central PMCID: PMC4681643.


8: Winterburn J, Pruessner JC, Sofia C, Schira MM, Lobaugh NJ, Voineskos AN,
Chakravarty MM. High-resolution In Vivo Manual Segmentation Protocol for Human
Hippocampal Subfields Using 3T Magnetic Resonance Imaging. J Vis Exp. 2015 Nov
10;(105):e51861. doi: 10.3791/51861. PubMed PMID: 26575133.


9: Nazeri A, Roostaei T, Sadaghiani S, Chakravarty MM, Eberly S, Lang AE,
Voineskos AN. Genome-wide variant by serum urate interaction in Parkinson's
disease. Ann Neurol. 2015 Nov;78(5):731-41. doi: 10.1002/ana.24504. Epub 2015 Aug
29. PubMed PMID: 26284320.


10: Voineskos AN, Winterburn JL, Felsky D, Pipitone J, Rajji TK, Mulsant BH,
Chakravarty MM. Hippocampal (subfield) volume and shape in relation to cognitive 
performance across the adult lifespan. Hum Brain Mapp. 2015 Aug;36(8):3020-37.
doi: 10.1002/hbm.22825. Epub 2015 May 9. PubMed PMID: 25959503.


11: Nazeri A, Chakravarty MM, Rajji TK, Felsky D, Rotenberg DJ, Mason M, Xu LN,
Lobaugh NJ, Mulsant BH, Voineskos AN. Superficial white matter as a novel
substrate of age-related cognitive decline. Neurobiol Aging. 2015
Jun;36(6):2094-106. doi: 10.1016/j.neurobiolaging.2015.02.022. Epub 2015 Feb 27. 
PubMed PMID: 25834938.


12: Wheeler AL, Wessa M, Szeszko PR, Foussias G, Chakravarty MM, Lerch JP,
DeRosse P, Remington G, Mulsant BH, Linke J, Malhotra AK, Voineskos AN. Further
neuroimaging evidence for the deficit subtype of schizophrenia: a cortical
connectomics analysis. JAMA Psychiatry. 2015 May;72(5):446-55. doi:
10.1001/jamapsychiatry.2014.3020. PubMed PMID: 25786193.


13: Suridjan I, Pollock BG, Verhoeff NP, Voineskos AN, Chow T, Rusjan PM, Lobaugh
NJ, Houle S, Mulsant BH, Mizrahi R. In-vivo imaging of grey and white matter
neuroinflammation in Alzheimer's disease: a positron emission tomography study
with a novel radioligand, [18F]-FEPPA. Mol Psychiatry. 2015 Dec;20(12):1579-87.
doi: 10.1038/mp.2015.1. Epub 2015 Feb 24. PubMed PMID: 25707397.


14: Anderson KK, Rodrigues M, Mann K, Voineskos A, Mulsant BH, George TP,
McKenzie KJ. Minimal evidence that untreated psychosis damages brain structures: 
a systematic review. Schizophr Res. 2015 Mar;162(1-3):222-33. doi:
10.1016/j.schres.2015.01.021. Epub 2015 Jan 30. Review. PubMed PMID: 25649287.


15: Nazeri A, Chakravarty MM, Rotenberg DJ, Rajji TK, Rathi Y, Michailovich OV,
Voineskos AN. Functional consequences of neurite orientation dispersion and
density in humans across the adult lifespan. J Neurosci. 2015 Jan
28;35(4):1753-62. doi: 10.1523/JNEUROSCI.3979-14.2015. PubMed PMID: 25632148;
PubMed Central PMCID: PMC4308611.


16: Anderson KK, Voineskos A, Mulsant BH, George TP, Mckenzie KJ. The role of
untreated psychosis in neurodegeneration: a review of hypothesized mechanisms of 
neurotoxicity in first-episode psychosis. Can J Psychiatry. 2014
Oct;59(10):513-7. Review. PubMed PMID: 25565683; PubMed Central PMCID:
PMC4197784.


17: Wheeler AL, Voineskos AN. A review of structural neuroimaging in
schizophrenia: from connectivity to connectomics. Front Hum Neurosci. 2014 Aug
25;8:653. doi: 10.3389/fnhum.2014.00653. eCollection 2014. Review. PubMed PMID:
25202257; PubMed Central PMCID: PMC4142355.


18: Kalache SM, Mulsant BH, Davies SJ, Liu AY, Voineskos AN, Butters MA, Miranda 
D, Menon M, Kern RS, Rajji TK. The impact of aging, cognition, and symptoms on
functional competence in individuals with schizophrenia across the lifespan.
Schizophr Bull. 2015 Mar;41(2):374-81. doi: 10.1093/schbul/sbu114. Epub 2014 Aug 
6. PubMed PMID: 25103208; PubMed Central PMCID: PMC4332950.


19: Suridjan I, Rusjan PM, Kenk M, Verhoeff NP, Voineskos AN, Rotenberg D, Wilson
AA, Meyer JH, Houle S, Mizrahi R. Quantitative imaging of neuroinflammation in
human white matter: a positron emission tomography study with translocator
protein 18 kDa radioligand, [18F]-FEPPA. Synapse. 2014 Nov;68(11):536-47. doi:
10.1002/syn.21765. Epub 2014 Jul 28. PubMed PMID: 25043159.


20: Voineskos AN. Genetic underpinnings of white matter 'connectivity':
heritability, risk, and heterogeneity in schizophrenia. Schizophr Res. 2015
Jan;161(1):50-60. doi: 10.1016/j.schres.2014.03.034. Epub 2014 Jun 2. Review.
PubMed PMID: 24893906; PubMed Central PMCID: PMC4250447.


21: Peters BD, Voineskos AN, Szeszko PR, Lett TA, DeRosse P, Guha S, Karlsgodt
KH, Ikuta T, Felsky D, John M, Rotenberg DJ, Kennedy JL, Lencz T, Malhotra AK.
Brain white matter development is associated with a human-specific haplotype
increasing the synthesis of long chain fatty acids. J Neurosci. 2014 Apr
30;34(18):6367-76. doi: 10.1523/JNEUROSCI.2818-13.2014. PubMed PMID: 24790207;
PubMed Central PMCID: PMC4004819.


22: Pipitone J, Park MT, Winterburn J, Lett TA, Lerch JP, Pruessner JC, Lepage M,
Voineskos AN, Chakravarty MM; Alzheimer's Disease Neuroimaging Initiative.
Multi-atlas segmentation of the whole hippocampus and subfields using multiple
automatically generated templates. Neuroimage. 2014 Nov 1;101:494-512. doi:
10.1016/j.neuroimage.2014.04.054. Epub 2014 Apr 29. PubMed PMID: 24784800.


23: Park MT, Pipitone J, Baer LH, Winterburn JL, Shah Y, Chavez S, Schira MM,
Lobaugh NJ, Lerch JP, Voineskos AN, Chakravarty MM. Derivation of high-resolution
MRI atlases of the human cerebellum at 3T and segmentation using multiple
automatically generated templates. Neuroimage. 2014 Jul 15;95:217-31. doi:
10.1016/j.neuroimage.2014.03.037. Epub 2014 Mar 21. PubMed PMID: 24657354.


24: Wheeler AL, Creed MC, Voineskos AN, Nobrega JN. Changes in brain functional
connectivity after chronic haloperidol in rats: a network analysis. Int J
Neuropsychopharmacol. 2014 Aug;17(8):1129-38. doi: 10.1017/S1461145714000042.
Epub 2014 Feb 14. PubMed PMID: 24524273.


25: Felsky D, Szeszko P, Yu L, Honer WG, De Jager PL, Schneider JA, Malhotra AK, 
Lencz T, Ikuta T, Pipitone J, Chakravarty MM, Lobaugh NJ, Mulsant BH, Pollock BG,
Kennedy JL, Bennett DA, Voineskos AN. The SORL1 gene and convergent neural risk
for Alzheimer's disease across the human lifespan. Mol Psychiatry. 2014
Oct;19(10):1125-32. doi: 10.1038/mp.2013.142. Epub 2013 Oct 29. PubMed PMID:
24166411; PubMed Central PMCID: PMC4004725.


26: Suridjan I, Rusjan PM, Voineskos AN, Selvanathan T, Setiawan E, Strafella AP,
Wilson AA, Meyer JH, Houle S, Mizrahi R. Neuroinflammation in healthy aging: a
PET study using a novel Translocator Protein 18kDa (TSPO) radioligand,
[(18)F]-FEPPA. Neuroimage. 2014 Jan 1;84:868-75. doi:
10.1016/j.neuroimage.2013.09.021. Epub 2013 Sep 21. PubMed PMID: 24064066.


27: Zai CC, Tiwari AK, Mazzoco M, de Luca V, Müller DJ, Shaikh SA, Lohoff FW,
Freeman N, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Remington G,
Kennedy JL. Association study of the vesicular monoamine transporter gene SLC18A2
with tardive dyskinesia. J Psychiatr Res. 2013 Nov;47(11):1760-5. doi:
10.1016/j.jpsychires.2013.07.025. Epub 2013 Sep 6. PubMed PMID: 24018103.


28: Lett TA, Voineskos AN, Kennedy JL, Levine B, Daskalakis ZJ. Treating working 
memory deficits in schizophrenia: a review of the neurobiology. Biol Psychiatry. 
2014 Mar 1;75(5):361-70. doi: 10.1016/j.biopsych.2013.07.026. Epub 2013 Sep 5.
Review. PubMed PMID: 24011822.


29: Hoppenbrouwers SS, Nazeri A, de Jesus DR, Stirpe T, Felsky D, Schutter DJ,
Daskalakis ZJ, Voineskos AN. White matter deficits in psychopathic offenders and 
correlation with factor structure. PLoS One. 2013 Aug 20;8(8):e72375. doi:
10.1371/journal.pone.0072375. eCollection 2013. PubMed PMID: 23977291; PubMed
Central PMCID: PMC3748110.


30: Wheeler AL, Chakravarty MM, Lerch JP, Pipitone J, Daskalakis ZJ, Rajji TK,
Mulsant BH, Voineskos AN. Disrupted prefrontal interhemispheric structural
coupling in schizophrenia related to working memory performance. Schizophr Bull. 
2014 Jul;40(4):914-24. doi: 10.1093/schbul/sbt100. Epub 2013 Jul 20. PubMed PMID:
23873858; PubMed Central PMCID: PMC4059434.


31: Felsky D, Voineskos AN. APOE ϵ 4, aging, and effects on white matter across
the adult life span. JAMA Psychiatry. 2013 Jun;70(6):646-7. doi:
10.1001/jamapsychiatry.2013.865. PubMed PMID: 23740051.


32: Nazeri A, Chakravarty MM, Felsky D, Lobaugh NJ, Rajji TK, Mulsant BH,
Voineskos AN. Alterations of superficial white matter in schizophrenia and
relationship to cognitive performance. Neuropsychopharmacology. 2013
Sep;38(10):1954-62. doi: 10.1038/npp.2013.93. Epub 2013 Apr 16. PubMed PMID:
23591167; PubMed Central PMCID: PMC3746702.


33: Voineskos AN, Foussias G, Lerch J, Felsky D, Remington G, Rajji TK, Lobaugh
N, Pollock BG, Mulsant BH. Neuroimaging evidence for the deficit subtype of
schizophrenia. JAMA Psychiatry. 2013 May;70(5):472-80. doi:
10.1001/jamapsychiatry.2013.786. PubMed PMID: 23467781.


34: Lett TA, Chakravarty MM, Felsky D, Brandl EJ, Tiwari AK, Gonçalves VF, Rajji 
TK, Daskalakis ZJ, Meltzer HY, Lieberman JA, Lerch JP, Mulsant BH, Kennedy JL,
Voineskos AN. The genome-wide supported microRNA-137 variant predicts phenotypic 
heterogeneity within schizophrenia. Mol Psychiatry. 2013 Apr;18(4):443-50. doi:
10.1038/mp.2013.17. Epub 2013 Mar 5. Erratum in: Mol Psychiatry. 2013
Oct;18(10):1146. Chakavarty, M M [corrected to Chakravarty, M M]. PubMed PMID:
23459466.


35: Winterburn JL, Pruessner JC, Chavez S, Schira MM, Lobaugh NJ, Voineskos AN,
Chakravarty MM. A novel in vivo atlas of human hippocampal subfields using
high-resolution 3 T magnetic resonance imaging. Neuroimage. 2013 Jul 1;74:254-65.
doi: 10.1016/j.neuroimage.2013.02.003. Epub 2013 Feb 13. PubMed PMID: 23415948.


36: Rajji TK, Voineskos AN, Butters MA, Miranda D, Arenovich T, Menon M, Ismail
Z, Kern RS, Mulsant BH. Cognitive performance of individuals with schizophrenia
across seven decades: a study using the MATRICS consensus cognitive battery. Am J
Geriatr Psychiatry. 2013 Feb;21(2):108-18. doi: 10.1016/j.jagp.2012.10.011. Epub 
2013 Jan 22. PubMed PMID: 23343484; PubMed Central PMCID: PMC3548068.


37: Barr MS, Farzan F, Rajji TK, Voineskos AN, Blumberger DM, Arenovich T,
Fitzgerald PB, Daskalakis ZJ. Can repetitive magnetic stimulation improve
cognition in schizophrenia? Pilot data from a randomized controlled trial. Biol
Psychiatry. 2013 Mar 15;73(6):510-7. doi: 10.1016/j.biopsych.2012.08.020. Epub
2012 Oct 3. PubMed PMID: 23039931.


38: Hoppenbrouwers SS, De Jesus DR, Stirpe T, Fitzgerald PB, Voineskos AN,
Schutter DJ, Daskalakis ZJ. Inhibitory deficits in the dorsolateral prefrontal
cortex in psychopathic offenders. Cortex. 2013 May;49(5):1377-85. doi:
10.1016/j.cortex.2012.06.003. Epub 2012 Jun 23. PubMed PMID: 22795183.


39: Voineskos AN, Felsky D, Kovacevic N, Tiwari AK, Zai C, Chakravarty MM,
Lobaugh NJ, Shenton ME, Rajji TK, Miranda D, Pollock BG, Mulsant BH, McIntosh AR,
Kennedy JL. Oligodendrocyte genes, white matter tract integrity, and cognition in
schizophrenia. Cereb Cortex. 2013 Sep;23(9):2044-57. doi: 10.1093/cercor/bhs188. 
Epub 2012 Jul 6. PubMed PMID: 22772651; PubMed Central PMCID: PMC3729194.


40: Rajji TK, Chow TW, Voineskos AN, Links KA, Miranda D, Mamo DC, Ismail Z,
Pollock BG, Mulsant BH. Cholinergic pathways and cognition in patients with
schizophrenia: a pilot study. Schizophr Res. 2012 Aug;139(1-3):46-52. doi:
10.1016/j.schres.2012.06.006. Epub 2012 Jun 22. PubMed PMID: 22727706.


41: Chakravarty MM, Felsky D, Tampakeras M, Lerch JP, Mulsant BH, Kennedy JL,
Voineskos AN. DISC1 and Striatal Volume: A Potential Risk Phenotype For mental
Illness. Front Psychiatry. 2012 Jun 19;3:57. doi: 10.3389/fpsyt.2012.00057.
eCollection 2012. PubMed PMID: 22723785; PubMed Central PMCID: PMC3378182.


42: Felsky D, Voineskos AN, Lerch JP, Nazeri A, Shaikh SA, Rajji TK, Mulsant BH, 
Kennedy JL. Myelin-associated glycoprotein gene and brain morphometry in
schizophrenia. Front Psychiatry. 2012 May 3;3:40. doi: 10.3389/fpsyt.2012.00040. 
eCollection 2012. PubMed PMID: 22563322; PubMed Central PMCID: PMC3342517.


43: Smith GN, Thornton AE, Lang DJ, Macewan GW, Ehmann TS, Kopala LC, Tee K,
Shiau G, Voineskos AN, Kennedy JL, Honer WG. Hippocampal volume and the
brain-derived neurotrophic factor Val66Met polymorphism in first episode
psychosis. Schizophr Res. 2012 Feb;134(2-3):253-9. doi:
10.1016/j.schres.2011.11.022. Epub 2011 Dec 21. PubMed PMID: 22192502.


44: Carmichael O, Xie J, Fletcher E, Singh B, DeCarli C; Alzheimer's Disease
Neuroimaging Initiative. Localized hippocampus measures are associated with
Alzheimer pathology and cognition independent of total hippocampal volume.
Neurobiol Aging. 2012 Jun;33(6):1124.e31-41. doi:
10.1016/j.neurobiolaging.2011.08.016. Epub 2011 Dec 14. PubMed PMID: 22169204;
PubMed Central PMCID: PMC3323681.


45: Ameis SH, Fan J, Rockel C, Voineskos AN, Lobaugh NJ, Soorya L, Wang AT,
Hollander E, Anagnostou E. Impaired structural connectivity of socio-emotional
circuits in autism spectrum disorders: a diffusion tensor imaging study. PLoS
One. 2011;6(11):e28044. doi: 10.1371/journal.pone.0028044. Epub 2011 Nov 23.
PubMed PMID: 22132206; PubMed Central PMCID: PMC3223195.


46: Shen KK, Fripp J, Mériaudeau F, Chételat G, Salvado O, Bourgeat P;
Alzheimer's Disease Neuroimaging Initiative. Detecting global and local
hippocampal shape changes in Alzheimer's disease using statistical shape models. 
Neuroimage. 2012 Feb 1;59(3):2155-66. doi: 10.1016/j.neuroimage.2011.10.014. Epub
2011 Oct 14. PubMed PMID: 22037419.


47: Cho Y, Seong JK, Jeong Y, Shin SY; Alzheimer's Disease Neuroimaging
Initiative. Individual subject classification for Alzheimer's disease based on
incremental learning using a spatial frequency representation of cortical
thickness data. Neuroimage. 2012 Feb 1;59(3):2217-30. doi:
10.1016/j.neuroimage.2011.09.085. Epub 2011 Oct 8. PubMed PMID: 22008371.


48: Eskildsen SF, Coupé P, Fonov V, Manjón JV, Leung KK, Guizard N, Wassef SN,
Østergaard LR, Collins DL; Alzheimer's Disease Neuroimaging Initiative. BEaST:
brain extraction based on nonlocal segmentation technique. Neuroimage. 2012 Feb
1;59(3):2362-73. doi: 10.1016/j.neuroimage.2011.09.012. Epub 2011 Sep 16. PubMed 
PMID: 21945694.


49: Lett TA, Tiwari AK, Meltzer HY, Lieberman JA, Potkin SG, Voineskos AN,
Kennedy JL, Müller DJ. The putative functional rs1045881 marker of neurexin-1 in 
schizophrenia and clozapine response. Schizophr Res. 2011 Nov;132(2-3):121-4.
doi: 10.1016/j.schres.2011.08.007. Epub 2011 Sep 3. PubMed PMID: 21890328.


50: Voineskos AN, Lett TA, Lerch JP, Tiwari AK, Ameis SH, Rajji TK, Müller DJ,
Mulsant BH, Kennedy JL. Neurexin-1 and frontal lobe white matter: an overlapping 
intermediate phenotype for schizophrenia and autism spectrum disorders. PLoS One.
2011;6(6):e20982. doi: 10.1371/journal.pone.0020982. Epub 2011 Jun 8. PubMed
PMID: 21687627; PubMed Central PMCID: PMC3110800.


51: Voineskos AN, Lerch JP, Felsky D, Tiwari A, Rajji TK, Miranda D, Lobaugh NJ, 
Pollock BG, Mulsant BH, Kennedy JL. The ZNF804A gene: characterization of a novel
neural risk mechanism for the major psychoses. Neuropsychopharmacology. 2011
Aug;36(9):1871-8. doi: 10.1038/npp.2011.72. Epub 2011 Apr 27. PubMed PMID:
21525856; PubMed Central PMCID: PMC3154105.


52: Bergen SE, Balhara YP, Christoforou A, Cole J, Degenhardt F, Dempster E,
Fatjó-Vilas M, Khedr Y, Lopez LM, Lysenko L, McGrath LM, Mühleisen TW, Neves FS, 
Nymberg C, Ozomaro U, Verweij KJ, Voineskos AN, Zai CC, O'Shea A, DeLisi LE.
Summaries from the XVIII World Congress of Psychiatric Genetics, Athens, Greece, 
3-7 October 2010. Psychiatr Genet. 2011 Jun;21(3):136-72. doi:
10.1097/YPG.0b013e3283469aa9. PubMed PMID: 21508788.


53: Schott JM; ADNI Investigators. Using CSF biomarkers to replicate genetic
associations in Alzheimer's disease. Neurobiol Aging. 2012 Jul;33(7):1486.e9-15. 
doi: 10.1016/j.neurobiolaging.2011.02.008. Epub 2011 Apr 3. PubMed PMID:
21459483; PubMed Central PMCID: PMC3150628.


54: Souza RP, Meltzer HY, Lieberman JA, Voineskos AN, Remington G, Kennedy JL.
Prolactin as a biomarker for treatment response and tardive dyskinesia in
schizophrenia subjects: old thoughts revisited from a genetic perspective. Hum
Psychopharmacol. 2011 Jan;26(1):21-7. PubMed PMID: 21305610.


55: Voineskos AN, Lerch JP, Felsky D, Shaikh S, Rajji TK, Miranda D, Lobaugh NJ, 
Mulsant BH, Pollock BG, Kennedy JL. The brain-derived neurotrophic factor
Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Arch
Gen Psychiatry. 2011 Feb;68(2):198-206. doi: 10.1001/archgenpsychiatry.2010.194. 
PubMed PMID: 21300947.


56: Tiwari AK, Zai CC, Likhodi O, Voineskos AN, Meltzer HY, Lieberman JA, Potkin 
SG, Remington G, Müller DJ, Kennedy JL. Association study of cannabinoid receptor
1 (CNR1) gene in tardive dyskinesia. Pharmacogenomics J. 2012 Jun;12(3):260-6.
doi: 10.1038/tpj.2010.93. Epub 2011 Jan 25. PubMed PMID: 21266946.


57: Voineskos AN, Farzan F, Barr MS, Lobaugh NJ, Mulsant BH, Chen R, Fitzgerald
PB, Daskalakis ZJ. The role of the corpus callosum in transcranial magnetic
stimulation induced interhemispheric signal propagation. Biol Psychiatry. 2010
Nov 1;68(9):825-31. doi: 10.1016/j.biopsych.2010.06.021. Epub 2010 Aug 12. PubMed
PMID: 20708172.


58: Souza RP, Remington G, Chowdhury NI, Lau MK, Voineskos AN, Lieberman JA,
Meltzer HY, Kennedy JL. Association study of the GSK-3B gene with tardive
dyskinesia in European Caucasians. Eur Neuropsychopharmacol. 2010
Oct;20(10):688-94. doi: 10.1016/j.euroneuro.2010.05.002. Epub 2010 Jun 3. PubMed 
PMID: 20605420.


59: Zai CC, Tiwari AK, Müller DJ, De Luca V, Shinkai T, Shaikh S, Ni X, Sibony D,
Voineskos AN, Meltzer HY, Lieberman JA, Potkin SG, Remington G, Kennedy JL. The
catechol-O-methyl-transferase gene in tardive dyskinesia. World J Biol
Psychiatry. 2010 Sep;11(6):803-12. doi: 10.3109/15622975.2010.486043. PubMed
PMID: 20586531.


60: Voineskos AN, Rajji TK, Lobaugh NJ, Miranda D, Shenton ME, Kennedy JL,
Pollock BG, Mulsant BH. Age-related decline in white matter tract integrity and
cognitive performance: a DTI tractography and structural equation modeling study.
Neurobiol Aging. 2012 Jan;33(1):21-34. doi: 10.1016/j.neurobiolaging.2010.02.009.
Epub 2010 Apr 3. PubMed PMID: 20363050; PubMed Central PMCID: PMC2945445.


61: Voineskos AN, Lobaugh NJ, Bouix S, Rajji TK, Miranda D, Kennedy JL, Mulsant
BH, Pollock BG, Shenton ME. Diffusion tensor tractography findings in
schizophrenia across the adult lifespan. Brain. 2010 May;133(Pt 5):1494-504. doi:
10.1093/brain/awq040. Epub 2010 Mar 17. PubMed PMID: 20237131; PubMed Central
PMCID: PMC2859148.


62: Hoppenbrouwers SS, Farzan F, Barr MS, Voineskos AN, Schutter DJ, Fitzgerald
PB, Daskalakis ZJ. Personality goes a long a way: an interhemispheric
connectivity study. Front Psychiatry. 2010 Nov 22;1:140. doi:
10.3389/fpsyt.2010.00140. eCollection 2010. PubMed PMID: 21423449; PubMed Central
PMCID: PMC3059614.


63: Novak G, Gallo A, Zai CC, Meltzer HY, Lieberman JA, Potkin SG, Voineskos AN, 
Remington G, Kennedy JL, Levesque D, Le Foll B. Association of the orphan nuclear
receptor NR4A1 with tardive dyskinesia. Psychiatr Genet. 2010 Feb;20(1):39-43.
doi: 10.1097/YPG.0b013e3283351221. PubMed PMID: 20010315.


64: Meyer JH, Wilson AA, Sagrati S, Miler L, Rusjan P, Bloomfield PM, Clark M,
Sacher J, Voineskos AN, Houle S. Brain monoamine oxidase A binding in major
depressive disorder: relationship to selective serotonin reuptake inhibitor
treatment, recovery, and recurrence. Arch Gen Psychiatry. 2009
Dec;66(12):1304-12. doi: 10.1001/archgenpsychiatry.2009.156. PubMed PMID:
19996035.


65: Zai CC, Tiwari AK, Basile V, de Luca V, Müller DJ, Voineskos AN, Remington G,
Meltzer HY, Lieberman JA, Potkin SG, Kennedy JL. Oxidative stress in tardive
dyskinesia: genetic association study and meta-analysis of NADPH quinine
oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes. Prog
Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):50-6. doi:
10.1016/j.pnpbp.2009.09.020. Epub 2009 Sep 22. PubMed PMID: 19778569.


66: Voineskos AN. Converging evidence for the Nogo-66 receptor gene in
schizophrenia. J Neurosci. 2009 Apr 22;29(16):5045-7. doi:
10.1523/JNEUROSCI.0477-09.2009. Review. PubMed PMID: 19386899.


67: Zai CC, Tiwari AK, Basile V, De Luca V, Müller DJ, King N, Voineskos AN,
Remington G, Meltzer HY, Lieberman JA, Potkin SG, Kennedy JL. Association study
of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients.
Pharmacogenomics J. 2009 Jun;9(3):168-74. doi: 10.1038/tpj.2009.2. Epub 2009 Feb 
24. PubMed PMID: 19238168.


68: Zai CC, Tiwari AK, De Luca V, Müller DJ, Bulgin N, Hwang R, Zai GC, King N,
Voineskos AN, Meltzer HY, Lieberman JA, Potkin SG, Remington G, Kennedy JL.
Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia. Eur
Neuropsychopharmacol. 2009 May;19(5):317-28. doi:
10.1016/j.euroneuro.2009.01.001. Epub 2009 Feb 13. PubMed PMID: 19217756.


69: Voineskos D, De Luca V, Macgregor S, Likhodi O, Miller L, Voineskos AN,
Kennedy JL. Neuregulin 1 and age of onset in the major psychoses. J Neural Transm
(Vienna). 2009 Apr;116(4):479-86. doi: 10.1007/s00702-008-0182-9. Epub 2009 Jan
28. PubMed PMID: 19184335.


70: Voineskos AN, O'Donnell LJ, Lobaugh NJ, Markant D, Ameis SH, Niethammer M,
Mulsant BH, Pollock BG, Kennedy JL, Westin CF, Shenton ME. Quantitative
examination of a novel clustering method using magnetic resonance diffusion
tensor tractography. Neuroimage. 2009 Apr 1;45(2):370-6. doi:
10.1016/j.neuroimage.2008.12.028. Epub 2008 Dec 29. PubMed PMID: 19159690; PubMed
Central PMCID: PMC2646811.


71: Zai CC, Romano-Silva MA, Hwang R, Zai GC, Deluca V, Müller DJ, King N,
Voineskos AN, Meltzer HY, Lieberman JA, Potkin SG, Remington G, Kennedy JL.
Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2
gene polymorphisms in tardive dyskinesia. Schizophr Res. 2008
Dec;106(2-3):248-52. doi: 10.1016/j.schres.2008.08.036. Epub 2008 Oct 5. PubMed
PMID: 18838251.


72: Voineskos AN, de Luca V, Bulgin NL, van Adrichem Q, Shaikh S, Lang DJ, Honer 
WG, Kennedy JL. A family-based association study of the myelin-associated
glycoprotein and 2',3'-cyclic nucleotide 3'-phosphodiesterase genes with
schizophrenia. Psychiatr Genet. 2008 Jun;18(3):143-6. doi:
10.1097/YPG.0b013e3282fa1874. PubMed PMID: 18496213.


73: Alkelai A, Baum A, Carless M, Crowley J, Dasbanerjee T, Dempster E, Docherty 
S, Hare E, Galsworthy MJ, Grover D, Glubb D, Karlsson R, Mill J, Sen S, Quinones 
MP, Vallender EJ, Verma R, Vijayan NN, Villafuerte S, Voineskos AN, Volk H, Yu L,
Zimmermann P, Delisi LE. The XVth World Congress of Psychiatric Genetics, October
7-11, 2007: Rapporteur summaries of oral presentations. Am J Med Genet B
Neuropsychiatr Genet. 2008 Mar 5;147B(2):233-77. doi: 10.1002/ajmg.b.30711.
PubMed PMID: 18297693.


74: Zai CC, De Luca V, Hwang RW, Voineskos A, Müller DJ, Remington G, Kennedy JL.
Meta-analysis of two dopamine D2 receptor gene polymorphisms with tardive
dyskinesia in schizophrenia patients. Mol Psychiatry. 2007 Sep;12(9):794-5.
PubMed PMID: 17767146.


75: Voineskos AN, Wilson AA, Boovariwala A, Sagrati S, Houle S, Rusjan P, Sokolov
S, Spencer EP, Ginovart N, Meyer JH. Serotonin transporter occupancy of high-dose
selective serotonin reuptake inhibitors during major depressive disorder measured
with [11C]DASB positron emission tomography. Psychopharmacology (Berl). 2007
Sep;193(4):539-45. Epub 2007 May 12. PubMed PMID: 17497139.


76: Segev F, Voineskos AN, Hui G, Law MS, Paul R, Chung F, Slomovic AR. Combined 
topical and intracameral anesthesia in penetrating keratoplasty. Cornea. 2004
May;23(4):372-6. PubMed PMID: 15097132.
